Literature DB >> 15353210

Transient cerebral ischemia induces site-specific hyperphosphorylation of tau protein.

Yi Wen1, Shaohua Yang, Ran Liu, James W Simpkins.   

Abstract

Neurofibrillary tangles (NFTs) are a pathological hallmark of many neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP17). However, the cellular origin and the consequence of the NFT formation are poorly understood. Epidemiological evidence suggests a much higher occurrence of dementia in stroke patients. This may represent the pathogenesis of sporadic AD, which accounts for the majority of AD occurrence. Here we show that after a transient cerebral ischemia, hyperphosphorylated tau accumulates in cortical neurons in a site-specific manner. The hyperphosphorylated tau presents a conformation similar to those present in human tauopathies, and colocalizes largely with signs of apoptosis. Our current study suggests that tau hyperphosphorylation may contribute to the brain damage induced by transient cerebral ischemia, and may be involved in the pathogenesis of neurodegenerative disorders in patients after stroke. Further, these results indicate that ischemic neuronal damage and apoptosis associates with tau hyperphosphorylation, and potentially NFTs formation. Finally, our results also suggest that neuronal apoptosis may be a therapeutic target in preventing tauopathy-related neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15353210     DOI: 10.1016/j.brainres.2004.05.106

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  57 in total

1.  Vasodilation by in vivo activation of astrocyte endfeet via two-photon calcium uncaging as a strategy to prevent brain ischemia.

Authors:  Yuanxin Chen; James Mancuso; Zhen Zhao; Xuping Li; Jie Cheng; Gustavo Roman; Stephen T C Wong
Journal:  J Biomed Opt       Date:  2013-12       Impact factor: 3.170

2.  Oligemic hypoperfusion differentially affects tau and amyloid-{beta}.

Authors:  Maya A Koike; Kim N Green; Mathew Blurton-Jones; Frank M Laferla
Journal:  Am J Pathol       Date:  2010-05-14       Impact factor: 4.307

3.  Targeting CDK5 post-stroke provides long-term neuroprotection and rescues synaptic plasticity.

Authors:  Johanna A Gutiérrez-Vargas; Herman Moreno; Gloria P Cardona-Gómez
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

4.  Differential changes in phosphorylation of tau at PHF-1 and 12E8 epitopes during brain ischemia and reperfusion in gerbils.

Authors:  W Gordon-Krajcer; E Kozniewska; J W Lazarewicz; H Ksiezak-Reding
Journal:  Neurochem Res       Date:  2006-12-27       Impact factor: 3.996

5.  CDK5 knockdown prevents hippocampal degeneration and cognitive dysfunction produced by cerebral ischemia.

Authors:  Johana A Gutiérrez-Vargas; Alejandro Múnera; Gloria P Cardona-Gómez
Journal:  J Cereb Blood Flow Metab       Date:  2015-06-24       Impact factor: 6.200

6.  Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease.

Authors:  Marta Cortes-Canteli; Justin Paul; Erin H Norris; Robert Bronstein; Hyung Jin Ahn; Daria Zamolodchikov; Shivaprasad Bhuvanendran; Katherine M Fenz; Sidney Strickland
Journal:  Neuron       Date:  2010-06-10       Impact factor: 17.173

7.  Hyperglycemia-induced tau cleavage in vitro and in vivo: a possible link between diabetes and Alzheimer's disease.

Authors:  Bhumsoo Kim; Carey Backus; Sangsu Oh; Eva L Feldman
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

8.  Modifications of tau protein after cerebral ischemia and reperfusion in rats are similar to those occurring in Alzheimer's disease - Hyperphosphorylation and cleavage of 4- and 3-repeat tau.

Authors:  Hiroki Fujii; Tetsuya Takahashi; Tomoya Mukai; Shigeru Tanaka; Naohisa Hosomi; Hirofumi Maruyama; Norio Sakai; Masayasu Matsumoto
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

9.  Expression of Tau protein in rats with cognitive dysfunction induced by cerebral hypoperfusion.

Authors:  Ji-Feng Li; Zhou Wang; Qin-Jian Sun; Yi-Feng Du
Journal:  Int J Clin Exp Med       Date:  2015-10-15

10.  The potential for estrogens in preventing Alzheimer's disease and vascular dementia.

Authors:  James W Simpkins; Evelyn Perez; Xiaofei Wang; Shaohua Yang; Yi Wen; Meharvan Singh
Journal:  Ther Adv Neurol Disord       Date:  2009-01       Impact factor: 6.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.